TR201917244A1 - Eltrombopag olami̇n i̇çeren kapsül - Google Patents

Eltrombopag olami̇n i̇çeren kapsül Download PDF

Info

Publication number
TR201917244A1
TR201917244A1 TR2019/17244A TR201917244A TR201917244A1 TR 201917244 A1 TR201917244 A1 TR 201917244A1 TR 2019/17244 A TR2019/17244 A TR 2019/17244A TR 201917244 A TR201917244 A TR 201917244A TR 201917244 A1 TR201917244 A1 TR 201917244A1
Authority
TR
Turkey
Prior art keywords
capsule
eltrombopag olamine
eltrombopag
olamine
thrombocytopenia
Prior art date
Application number
TR2019/17244A
Other languages
English (en)
Inventor
Tok Gülçi̇n
Yildirim Edi̇z
Sünel Fati̇h
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2019/17244A priority Critical patent/TR201917244A1/tr
Priority to EP20884244.3A priority patent/EP4054566A4/en
Priority to PCT/TR2020/050997 priority patent/WO2021091510A1/en
Publication of TR201917244A1 publication Critical patent/TR201917244A1/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4152—1,2-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. antipyrine, phenylbutazone, sulfinpyrazone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Mevcut buluş, trombositopeni tedavisinde kullanılmak üzere, eltrombopag olamin ve en az bir bağlayıcı içeren farmasötik kapsül kompozisyonu ile ilgilidir.
TR2019/17244A 2019-11-07 2019-11-07 Eltrombopag olami̇n i̇çeren kapsül TR201917244A1 (tr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
TR2019/17244A TR201917244A1 (tr) 2019-11-07 2019-11-07 Eltrombopag olami̇n i̇çeren kapsül
EP20884244.3A EP4054566A4 (en) 2019-11-07 2020-10-27 CAPSULE COMPRISING ELTROMBOPAG OLAMINE
PCT/TR2020/050997 WO2021091510A1 (en) 2019-11-07 2020-10-27 A capsule comprising eltrombopag olamine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2019/17244A TR201917244A1 (tr) 2019-11-07 2019-11-07 Eltrombopag olami̇n i̇çeren kapsül

Publications (1)

Publication Number Publication Date
TR201917244A1 true TR201917244A1 (tr) 2021-05-21

Family

ID=75848795

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/17244A TR201917244A1 (tr) 2019-11-07 2019-11-07 Eltrombopag olami̇n i̇çeren kapsül

Country Status (3)

Country Link
EP (1) EP4054566A4 (tr)
TR (1) TR201917244A1 (tr)
WO (1) WO2021091510A1 (tr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114099435A (zh) * 2021-12-16 2022-03-01 南京威凯尔生物医药科技有限公司 一种艾曲泊帕乙醇胺纳米胶束及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ECSP077628A (es) 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
AU2012201288B2 (en) * 2007-05-03 2014-05-01 Novartis Ag Novel pharmaceutical composition
CN107693515B (zh) * 2016-08-08 2022-04-29 广东东阳光药业有限公司 含碱化剂和艾曲泊帕的药物组合物及其用途
CN106361719A (zh) * 2016-08-25 2017-02-01 浙江万晟药业有限公司 一种艾曲泊帕液体胶囊及其制备方法
WO2018078644A1 (en) * 2016-10-24 2018-05-03 Hetero Labs Limited Orally disintegrating tablets of eltrombopag
EP3409272B1 (en) * 2018-03-07 2020-06-24 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical composition comprising eltrombopag olamine, reducing sugar, and polymeric binder

Also Published As

Publication number Publication date
WO2021091510A1 (en) 2021-05-14
EP4054566A4 (en) 2023-12-06
EP4054566A1 (en) 2022-09-14

Similar Documents

Publication Publication Date Title
PH12020550622A1 (en) Kras g12c inhibitors
EA201890204A1 (ru) Антибактериальные соединения
MX2020006595A (es) Oxadiazoles fungicidas.
MD3728207T2 (ro) Chinazolinone ca inhibitori PARP14
EA201992504A1 (ru) Ингибиторы magl на основе пиразола
MX2018013240A (es) Composiciones antiirritantes sinergisticas de taurina y aloe.
BR112021016056A2 (pt) Anticorpos de claudina 6 e usos dos mesmos
PH12016502347A1 (en) 1 -(cyclopent-2-en-1 -yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as cxcr2 inhibitors
TR201900680T4 (tr) CXCR3 Reseptör modülatörleri olarak hidroksialkil- piperazin türevleri.
MX2021001786A (es) Antagonistas de integrina.
EA202191114A1 (ru) Производные пиридинилсульфонамида, фармацевтические композиции и их применение
UY37967A (es) Compuestos y métodos para la reducción de la expresión de snca
TR201902686T4 (tr) Aurora A kinaz inhibitörü.
EA201892714A1 (ru) Имидазолиновые соединения в качестве ингибиторов эластазы нейтрофилов человека
CL2020002597A1 (es) Métodos para preparar composiciones proteicas estables
TR201901977T4 (tr) Cxcr3 reseptörü modülatörleri olarak (r)-2-metil-piperazin türevleri.
TR201916829A2 (tr) Dapagli̇flozi̇n ve metformi̇n i̇çeren çi̇ft katmanli tablet formülasyonlari
EA201891610A1 (ru) Производные 3-(карбоксиэтил)-8-амино-2-оксо-1,3-диазаспиро[4.5]декана
MX2020002802A (es) Anticuerpos de cadena pesada que se unen a ectoenzimas.
TR201917244A1 (tr) Eltrombopag olami̇n i̇çeren kapsül
MX2020011027A (es) Constructos de anticuerpos biespecíficos trivalentes.
EA202090270A1 (ru) Новые замещенные производные ксантина
MX2020001424A (es) Una composición para el cuidado personal.
BR112017024126B8 (pt) Composições farmacêuticas, composto a micronizado e/ou pelo menos um sal farmaceuticamente aceitável micronizado do composto a e uso dos mesmos
TR201722367A2 (tr) Lakozami̇d i̇çeren parenteral uygulmaya yöneli̇k farmasöti̇k kompozi̇syonlar